Back to People & Entities
Roche Holding AG's
Organization
2
Total Mentions
2
Documents
14
Connected Entities
Organization referenced in documents
Document Mentions (2)
EFTA00689626.pdf
1 mentionEFTA00689626
gh the study wasn't designed to show statistically significant differences, the group treated with AVA-101 got an average of two extra injections of Roche Holding AG's Lucentis, compared with four for the control group. "When a company is valued at $1 billion at a phase 2 trial, the expectations are quite high," sa
EFTA01368453.pdf
1 mentionEFTA01368453
gh the study wasn't designed to show statistically significant differences, the group treated with AVA-101 got an average of two extra injections of Roche Holding AG's Lucentis, compared with four for the control group. "When a company is valued at $1 billion at a phase 2 trial, the expectations are quite high," sa
Sponsored
Connected Entities(14)
Roche
OrganizationPharmaceutical company
2 docs2 co-mentions
RE
Regeneron
PersonSurname reference in documents
2 docs2 co-mentions
Bloomberg L.P.
OrganizationAmerican privately held financial, software, data, and media company
2 docs2 co-mentions
Regeneron Pharmaceuticals Inc.
OrganizationOrganization referenced in documents
2 docs2 co-mentions
AD
Avalanche Drops
PersonName reference in documents
2 docs2 co-mentions
DB
Danielle Burger
PersonName reference in documents
2 docs2 co-mentions
GA
Gbola Amusa
PersonName reference in documents
2 docs2 co-mentions
GP
Gary Putka
PersonName reference in documents
2 docs2 co-mentions
Avalanche Biotechnologies Inc.
OrganizationOrganization referenced in documents
2 docs2 co-mentions
AVA-101
OrganizationOrganization referenced in documents
2 docs2 co-mentions
Lucentis
OrganizationOrganization referenced in documents
2 docs2 co-mentions
Chardan Capital Markets
OrganizationOrganization referenced in documents
2 docs2 co-mentions
Avalanche
OrganizationOrganization referenced in documents
2 docs2 co-mentions
Chalberg
OrganizationOrganization referenced in documents
2 docs2 co-mentions